Breast cancer is the most common malignancy in women worldwide. While advance have been made in treatment this disease still accounts for the second largest number of cancer deaths in women in the US. These deaths are largely due to metastatic disease. This proposal is based upon observations by project leaders (PL) and other members of the PPG that tumor associated macrophages (TAMs) play a critical role in promoting the rate-limiting steps of metastasis - tumor cell intravasation and extravasation. Central to these observations was the definition by the PL of TAM sub-populations defined by their transcriptome and cell surface markers. Thus different populations have individual functions including in the primary tumor the stimulation of angiogenesis, tumor cell invasion and intravasation as well as at metastatic sites extravasation and persistent growth. In this proposal we have three specific aims:
Aim 1 : Mechanisms for Monocyte Recruitment and Macrophage Differentiation in the Primary Tumor. In this aim the mechanism of recruitment and differentiation of the different populations to the primary tumor will be studied with a particular focus upon those macrophages that stimulate invasion and intravasation. We will use novel methods for fate mapping macrophages to explore their origin and plasticity in the tumor.
Aim 2 : Molecular basis for the Promotion of Extravasation by of Metastasis Associated Macrophages.
This aim will define the signaling pathways that convert macrophages into those that promote extravasation of tumor cells. It will discover the mechanism whereby macrophages enable tumor cells to egress through the endothelial layer.
Aim3 : Definition of Pro-Tumoral Functions of Human breast Cancer TAMs Studies will be translated from mouse models into human breast cancer. Human TAMs from various disease sub-types will be isolated followed by ex vivo assays for function. These assays together with transcriptional profiles will define signaling pathways and determine whether they parallel those found in mice. Together these studies will enable therapeutic targets aimed at sub-populations of macrophages rather than the pan- macrophage therapeutics currently in trial that have toxicities because that target all resident macrophages.

Public Health Relevance

In the US -250,000 new cases of invasive ductal breast carcinoma are diagnosed each year with 40,000 deaths. Over the last decade statistics show an improvement in survival for women with local disease but no change for those with metastatic disease. This depressing statistic demands new therapeutic approaches. In this application we propose that one strategy to improve treatment is to target the tumor microenvironment and particularly the macrophages within it in order to remove their pro-tumor support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA100324-11A1
Application #
8669391
Study Section
Special Emphasis Panel (ZCA1-RPRB-C (J1))
Project Start
2003-06-01
Project End
2019-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
11
Fiscal Year
2014
Total Cost
$244,602
Indirect Cost
$98,134
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Khalil, Bassem D; Hanna, Samer; Saykali, Bechara A et al. (2014) The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. Exp Cell Res 321:109-22
Noy, Roy; Pollard, Jeffrey W (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49-61
Roh-Johnson, M; Bravo-Cordero, J J; Patsialou, A et al. (2014) Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 33:4203-12
Bergman, Aviv; Condeelis, John S; Gligorijevic, Bojana (2014) Invadopodia in context. Cell Adh Migr 8:273-9
Zhou, Z N; Sharma, V P; Beaty, B T et al. (2014) Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 33:3784-93
Weitsman, Gregory; Lawler, Katherine; Kelleher, Muireann T et al. (2014) Imaging tumour heterogeneity of the consequences of a PKC?-substrate interaction in breast cancer patients. Biochem Soc Trans 42:1498-505
Gligorijevic, Bojana; Bergman, Aviv; Condeelis, John (2014) Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol 12:e1001995
Hanna, Samer; Khalil, Bassem; Nasrallah, Anita et al. (2014) StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion. Int J Oncol 44:1499-511
Stanley, E Richard; Chitu, Violeta (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol 6:
Rohan, Thomas E; Xue, Xiaonan; Lin, Hung-Mo et al. (2014) Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. J Natl Cancer Inst 106:

Showing the most recent 10 out of 127 publications